ProBioGen partners with Granite Bio for cell line development and GMP manufacturing services
Granite Bio's lead candidate is a novel monoclonal antibody for treatment of autoimmune and certain cancer indications. B
Granite Bio's lead candidate is a novel monoclonal antibody for treatment of autoimmune and certain cancer indications. B
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
The award was presented to her during a virtual ceremony on the occasion of 8th International Day of Yoga on 21st June 2022.
Bringing next-gen cannabinoid therapeutics to cancer patients
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
Expanding diagnostics footprint in East India
The IDCF programme is being implemented from 13th June to 27th June, 2022 in the states/UTs and the goal is to attain zero child deaths due to childhood diarrhoea
Cantourage introduces second Clever Leaves medical cannabis product to the German market
Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
Subscribe To Our Newsletter & Stay Updated